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Background: There are strong indications for a causal association between areca-nut consumption and cancers. In
Meghalaya, India, the variety of areca-nut is used as raw and unprocessed form whose chemical composition and
pharmacological actions have been reported. Yet we know little on the initial pathway involved in areca-nut
associated carcinogenesis since it is difficult to assess its effects on genetic alterations without interference of other
compounding factors. Therefore, present study was undertaken in mice to verify the ability of raw areca-nut (RAN)
to induce cancer and to monitor the expression of certain genes involved in carcinogenesis. This study was not
intended to isolate any active ingredients from the RAN and to look its action.
Methods: Three groups of mice (n = 25 in each) were taken and used at different time-points for different
experimental analysis. The other three groups of mice (n = 15 in each) were considered for tumor induction studies.
In each set, two groups were administered RAN-extract ad libitum in drinking water with or without lime. The
expression of certain genes was assessed by conventional RT-PCR and immunoblotting. The mice were given the
whole RAN-extract with and without lime in order to mimic the human consumption style of RAN.
Results: Histological preparation of stomach tissue revealed that RAN induced stomach cancer. A gradual increase
in the frequency of precocious anaphase and aneuploid cells was observed in the bone marrow cells with a greater
increment following RAN + lime administeration. Levels of p53, Bax, Securin and p65 in esophageal and stomach
cells were elevated during early days of RAN exposure while those of different mitotic checkpoint proteins were
downregulated. Apoptotic cell death was detected in non-cancerous stomach cells but not in tumor cells which
showed overexpression of Bax and absence of PARP.
Conclusion: Present study suggested (a) RAN induces stomach cancer, however, presence of lime promoted higher
cell transformation and thereby developed cancer earlier, (b) perturbations in components of the chromosome
segregation machinery could be involved in the initial process of carcinogenicity and (c) the importance of
precocious anaphase as a screening marker for identification of mitotic checkpoint defects during early days.
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Esophageal squamous cell carcinoma (ESCC) and the
gastric cancers are most common cancers in India, with
the highest incidence of ESCC being in north-eastern
states of India [1]. There are strong indications for a
causal association between areca-nut or quid chewing
habits and these cancers. Several studies in different
animal species have shown positive induction of tumors
in both target (cheek-pouch, esophagus and stomach)
and non-target (lung and liver) tissues when arecoline
(ARC) or areca-nut extract was administered by different
means such as oral intubation [2], mixed with the diet
[3], and cheek-pouch application [4]. Therefore, it seems
that metabolic activation of alkaloids is needed for the
final conversion into the ultimate carcinogens, which is
strongly influenced by physiological conditions and pres-
ence of certain factors [5]. Reports have indicated gener-
ation of reactive oxygen species (ROS) from areca-nut
ingredients under alkaline conditions [6,7]. Due to the
presence of lime in betel-quid preparation, areca-nut
chewers’ saliva typically changes from neutral to an alka-
line condition which could be ideal for generating ROS
[7]. Nair et al. [6] have also noted that besides ARC,
auto-oxidation of areca-nut polyphenols could generate
H2O2 and superoxide radicals at alkaline pH.
In the State of Meghalaya, India, the variety of areca
nut, locally called ‘kwai’, is used as unripe and unpro-
cessed raw form which has higher contents of alkaloids,
polyphenols and tannins as compared to the dried form
[8]. The betel-quid used in Meghalaya contains raw
areca-nut (RAN), lime paste and small portion of betel-
leaf without tobacco and other constituents. Here people
swallow the whole quid after chewing instead of spitting
it out which could be an important factor for ESCC and
stomach cancer. Recently, 40% esophageal cancer sam-
ples collected from patients of Meghalaya state having
only RAN-chewing habit showed deletion of the micro-
satellite markers D9S1748 and D9S1749, located close to
exon 1β of CDKN2A/ARF gene at 9p21. The promoter
hypermethylation of CDKN2A gene was significantly
higher in the samples with the habit of RAN-chewing
alone than those having the habit of use both RAN and
tobacco [9]. Till now, we do not know much on the
initial pathway involves in betel-nut associated carcino-
genesis in esophagus and stomach. It is also difficult to
assess the effects of purely and predominantly areca-
nut-induced genetic alterations in human without inter-
ference by other compounding factors like tobacco
chewing or smoking, alcohol consumption, various types
of non-vegeterian foods etc. Moreover, the presence of
lime makes an alkaline condition which is not ideal for
in vitro cell culture and therefore the effect of areca-nut
cannot be tested in cell culture systems. In view of these,
the present study was carried out in mice to verify theability of RAN-extract with or without lime, to induce
cancer and simultaneously evaluate the expression pat-
tern of certain genes which play an important role in the
initial process of carcinogenesis.
The chemical composition and pharmacological actions
of areca-nut have been reported and reviewed by several
workers [10,11]. Several animal studies have confirmed
that areca-nut products and betel specific nitrosamines,
have the ability to induce neoplastic changes in experi-
mental animals [11]. Considerable evidence suggests that
areca-nut-alkaloids, predominantly arecoline (ARC) are
the major factors in BN-toxicity [11]. It was shown that
ARC can induce DNA damages in mouse bone marrow
cells [12] and such DNA damages can be reduced when
ARC is administered with N-acetyl-L-cysteine [13]. There-
fore, it is worth mentioning that the present study was not
intended to isolate any active ingredients from the RAN
and to look its action. The aim of the study was to identify
the initial pathway involved in RAN associated carcino-
genesis in mice and therefore mice were given the whole
RAN-extract with and without lime in order to mimic the
consumption habit of human.
Several genes, like p53, p65, Securin and many others,
are known to be usually overexpressed during carcino-
genesis [14-16]. Moreover, genetic instability is also asso-
ciated with chromosome instability (CIN) which leads to
aneuploidy, a hallmark of cancer. Such aneuploidy may
facilitate tumorigenesis through the loss of tumor sup-
pressor gene function. It has been observed that the
partial loss of mitotic checkpoint control leads to CIN in
human cancer cells [17,18]. Therefore, in the present
study, we evaluated the expression pattern of p53, p65,
Securin and several mitotic and spindle assembly check-
point genes at different time-points. We observed that
RAN can induce stomach cancer by perturbing the com-
ponents of the chromosome segregation machinery.Methods
Preparation of extracts
After shelling the fibrous coats from unprocessed raw
and unripe areca-nut (RAN), 100 g of RAN were ground
and suspended in 125 ml of distilled water and mixed
thoroughly to give a smooth paste for preparation of an
aqueous extract of RAN. After 24 h, the paste was
stirred for 3 h at 37°C and the aqueous extract was col-
lected by centrifugation. This extraction procedure was
repeated once more by adding 125 ml of water to the
residue. Both extracts were pooled, representing 100 g of
RAN in 250 ml distilled water, filtered and frozen at -
80°C. The filtrate was lyophilized in a Secfroid Lyolab
BII Lyophilizer (Denmark). The lyophilized mass was
kept at 4°C until use. The extract contained 0.9 g/100 g
water-extractable material.
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Swiss albino mice (25–30 gm), 2–3 months old were
maintained in the laboratory in community cages in a
room with controlled temperature (20 ± 2°C) and con-
trolled lighting (12 h light; 12 h dark). Standard mouse
diet (NMC Oil Mills Ltd., Pune, India) and water ad
libitum were used in all experiments. The experiments
were conducted in compliance with institutional guide-
lines and approved by our “Institutional Standards for
Animal Care and Use” Board.
In Set-1, three groups of mice (n = 25 in each) were
taken which were used at different time-points for differ-
ent experimental analysis. In Set-2, three groups of mice
(n = 15 in each) were considered for tumor induction
studies. Figure 1 gives a schematic overview about the
overall experimental protocol which was considered in
this study. In each set, one group was treated with sim-
ple drinking water considered to be untreated whereas
two groups were administered RAN extract ad libitum
in the drinking water with or without lime (pH 9.8). It
was estimated that each mouse consumed 1 mg of
extract per day. Such oral administeration was continued
for 60 days after which the dose was increased from
1 mg to 2 mg per day till 120 days. Likewise, every
60 days later the dose was increased by 1 mg per day
consumption.Preparation of metaphases and scoring of chromosomal
aberrations
For metaphase preparation, bone marrow cells (BMC)
were collected from two mice per point from untreated,
15 and 30 days of treated group and three mice per
point for the rest. In the treated groups, BMC were col-
lected after 15, 30, 60, 120 and 180 days of treatment.
BMC were also collected from the two mice having
stomach tumor. BMC were collected after 2 h colchicine


























Figure 1 Flowdiagramof experimental design for the analysis of raw arecdislocation. The femurs were dissected out and the BMC
were flushed out by injecting 2 ml 0.075 M KCl pre-
warmed to 37°C. Cells were treated in hypotonic solu-
tion for 15 min and fixed in acetic acid and methanol
(1:3). Slides were prepared by the flame drying method,
stained in 5% Giemsa for 5 min and mounted in syn-
thetic medium. Images of metaphase spreads were taken
under Zeiss Axioskop microscope (Germany).
For chromosomal study, the slides were coded at
random and at least 100 well spread metaphase plates
were selected for study from each mouse. We performed
chromosome counts on metaphase spread. Chromosome
aberrations were scored as isochromatid breaks and
chromatid breaks. See Extended Experimental Proce-
dures for details in the Additional file 1: Supplemental
Information.Immunoblotting
Cells from bone-marrow, esophagus (by scratching inner
layer) and stomach (by scratching inner part) were
washed twice with PBS (phosphate buffered saline) and
were lysed in radioimmuno-precipitation buffer (0.1%
SDS, 2 mM EDTA, 1% NP-40, 1% sodium deoxycholate,
50 mM sodium fluoride and 100 U/ml aprotinin). After
30 min of incubation on ice, the cell lysates were
centrifuged for 15 min at 4°C and the amount of protein
was determined using the bicinchoninic acid protein
assay. Equal amount of protein (40 μg) from each sample
was loaded in each well; equal loading was further veri-
fied by immunoblotting with actin antibodies. Samples
were loaded in Novex Tris-Glycine 4-20% gradient gels
and electrophoresis was performed in NuPAGE electro-
phoresis system (Invitrogen, USA). Proteins were trans-
ferred to a Polyvinylidene difluoride (PVDF) membrane
(Sigma) following standard protocol. The membranes
were probed with a 1:1000 dilution of a mouse monoclo-
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ab3305; Abcam, USA), β-actin (AC-15; ab6276; Abcam,
USA) and rabbit polyclonal antibody against NF-κβ P65
(ab31481; bcam, USA). Blots were washed 3 times for
10 min each in TBST buffer pH 7.6 (1 M Tris Cl, 5 M
NaCl and 0.05% Tween 20) and incubated with secondary
antibody (alkaline–phosphatase conjugated anti-mouse
IgG or alkaline–phosphatase conjugated antirabbit IgG
1:2000; Abcam, USA) for 1 h at room temperature. After
extensive washing, the blot was immersed in 4 ml sub-
strate solution of BCIP/NBT (Bangalore Genei, India).
Sufficient staining was obtained within 15 min. Each im-
munoblotting was performed in three mice per-point.Histopathological evaluation
Stomach tissue was collected from untreated control and
from two RAN+ lime treated mice with tumor. In another
set, stomach tissue was also collected from untreated as
well as from the groups that treated for 300 days with
RAN-extract with and without lime. Three mice were
selected randomly from each group. These mice did not
have any indication of tumor externally. Tissue sections
(5–7 μm) were processed for histological sectioning as per
standard protocol [19] and stained with hematoxylin and
eosin [20]. Sections were then observed under a light
microscope and photographed (Carl Zeiss, Germany).RNA extraction and conventional RT-PCR analysis
Cells were collected by scratching the inner layer of
esophagus and stomach from untreated control, RAN and
RAN+ lime treated mouse (three mice per point). Bone
marrow cells were collected from the femur bone of the
mouse. Total RNA was isolated with Trizol and then puri-
fied using the RNeasy Mini Kit (Qiagen) according to the
manufacturer’s protocol. Reverse transcription was
performed with 1 μg of total RNA from each sample using
Quantiscript Reverse Transcriptase, Quantiscript RT-
buffer and RT Primer-mix of QuantiTect Reverse Tran-
scription kit (Qiagen GmbH, Hilden, Germany) according
to the manufacturer's protocol. Amplification of cDNA
was conducted in 20 μl solution containing 2 μl cDNA, 10
pmol primer pairs for aurora A, aurora B, Mad2, Bub1
and GAPDH (for primer sequences, see Additional file 1:
Supplemental Information) respectively, and 10 μl of RT
qPCR Master mix (Qiagen GmbH, Hilden, Germany).
The PCR consisted of initial denaturation at 94°C for
5 min, followed by 30 reaction cycles (30 seconds at 94°C,
30 seconds at 60°C, and 30 seconds at 72°C) and a final
cycle at 72°C for 10 min. GAPDH was used as internal
control. All PCR products were electrophoretically sepa-
rated on ethidium bromide-stained agarose gel and visual-
ized with UV light.Flow cytometric analysis of cells
Mouse bone marrow cells and the cells collected by
scratching the inner layer of the esophagus and stomach
of both untreated and treated for 260 days with RAN with
or without lime were fixed with 70% ethanol. Stomach
tumor cells were also collected and fixed. The fixed cells
were washed in PBS and resuspended in 500 μl of
propidium iodide solution (50 μg/ml propidium iodide,
0.2 mg/ml RNase) for 1 h at room temperature in dark.
10,000 cells were acquired for each sample and analysed
with a FACS Calibur (Becton-Dickinson). CELLQuest Pro
software was used to quantify cell cycle compartments to
estimate the percentage of cells distributed in the different
cell cycle phases.
Annexin V labelling studies
Apoptotic cell death was evaluated using annexinV–
fluorescein isothiocyanate method in the stomach tumor
cells and also in the inner layer of cells of the stomach
and esophagus of untreated and RAN with and without
lime treated mouse after 260 days of continuous adm-
inisteration. The cell pellet was resuspended in PBS.
Cells were stained with propidium iodide and Annexin-
V-FITC using BD PharmingenTM Annexin V: FITC
Apoptosis Detection Kit (BD-Pharmingen Biosciences,
San Diego, CA) as per manufacturer’s instruction. Briefly,
after collecting and washing twice with PBS, cells were
resuspended in the binding buffer (500 μl). FITC-
Annexin-V (5 μl) was added to the cells followed by
addition of 5 μl PI according to the protocol. The samples
were then incubated for 15 min in the dark at room
temperature and subjected to flow cytometry evaluation.
Statistical analysis
Values are expressed as mean ± SEM or mean ± SEM for
control and experimental samples and statistical analysis
were performed by Student’s t test with GraphPad Prism
software 5.1. The values were considered statistically sig-
nificant, if the p value was 0.05 or less.
Results
General observations
Out of fifteen mice, two mice developed stomach cancer
after 220 and 256 days of feeding of RAN extract with
lime (Figure 2A a and b). No tumor was developed in
mouse either untreated or administered with RAN only.
The histological section clearly differentiated between nor-
mal (Figure 2A c) and tumorous stomach (Figure 2A d-f).
However, histological preparation of stomach tissue was
also made from three apparently normal looking mice
randomly selected from this group after 300 days of feed-
ing with RAN-extract with and without lime. Both RAN
with and without lime showed its ability to induce cancer














Figure 2 Dissected mouse and histopathology of both normal and tumor tissue of stomach following treatment with RAN with and
without lime. A. Dissected mouse with (a) normal stomach and (b) tumorous stomach indicated with an arrow. Histopathology of normal
(c) and tumour stomach (d,e and f) that induced by RAN extract with lime. The arrows indicate ulcerated neoplasm in (d) and tumor giant cells
in (e and f). The magnification is indicated either 10X or 40X. B. Histopathology of normal and tumorous stomach of mice following RAN and
RAN + lime treatment for 300 days. In all panels, “Normal” indicates mice with no tumor, “Dysplasia” indicates mice with precancerous stomach
tissue. “Carcinoma” indicates mice with tumorous stomach. Dysplasia shows anisokaryosis (variation in size of nuclei) and anisocytosis (variation in
size of cells). The magnification is indicated either 10X, 40X and 100X.
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three mice treated with RAN+ lime showed carcinoma
(Figure 2B).
Studied on metaphase spreads
To determine whether continuous administeration of
RAN extract (from 15 to 180 days) with or without lime
has any effect on chromosomes, we studied metaphase
spreads, after 2 h treatment with colchicine, in bone
marrow samples. Data revealed a gradual increase in mi-
totic figures with prematurely separated sister chroma-
tids (Figure 3A and C) both in RAN and RAN + lime
administered mouse, compared with none in untreated
mice. It is also clear from the study that RAN + lime ad-
ministered mouse bone marrow showed significantly
higher frequency of such precocious anaphase than only
RAN administered (Figure 3A). After 180 days of con-
tinuous administeration of RAN + lime, 34.4% preco-
cious anaphase compared with 18.4% (p = 0.002) in
RAN-administered mouse BMC were seen.We counted the number of chromosomes in metaphase
spreads to understand the significance of precocious ana-
phases in relation to chromosome stability. The untreated
mice have a stable (2n = 40) karyotype (Figure 3B) and did
not show any aneuploid cells. We did observe low fre-
quency of aneuploid cells (Figure 3D-I; Table 1) in RAN-
administered, with and without lime, for 120 days and it
was noted that the frequency of aneuploid cells was
increased gradually. The mean frequency (13.8%) of aneu-
ploid cells was scored in both the stomach tumor bearing
mice. Overall, the frequency of aneuploid cells was more
following RAN+ lime administeration than RAN alone
(Table 1).
Chromosome aberrations were scored mainly as chro-
matid breaks. Very low frequency of isochromatid breaks
was observed and no exchange aberrations were found.
The frequency of chromatid breaks and aberrant me-
taphases was increased gradually from 60 to 180 days of
RAN-administeration with or without lime. The fre-







































Figure 3 Karyotype analysis of genomic instability in bone marrow cells of mouse after exposure to RAN extract with (RAN + L) or
without lime (RAN). (A) Percentage of metaphases with premature sister-chromatid separation. Two mice per point for untreated, 15 and
30 days of treated group and three mice per point for the rest. At least 100 metaphases were scored to each mouse. (B) Normal metaphase
spread from mouse bone marrow cells. (C) Premature sister-chromatid separation from mouse exposed to RAN. Brackets show sister-chromatids
lying separated in mitotic figures that show the phenotype. (D and E) Metaphase spread showed 37 and 38 chromosomes, respectively. (F,G
and H) Metaphase spread showed more than 60 chromosomes. (I) showed more than 80 chromosomes.
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rations was more in both the advanced stomach tumor
bearing mice. (For aberration details, see Additional file 1:
Supplementary Information).
Reduced expression of mitotic and spindle checkpoint
genes in RAN-treated mice
In view of the above studies, we examined the expre-
ssion of AuroraA, AuroraB, MAD2 and Bub1 genes in
bone marrow, esophageal and stomach cells of those
mice which were untreated or administered RAN extract
with and without lime for 120, 180 and 260 days. The
conventional RT-PCR results (Figure 4) showed that
cells collected from esophagus and stomach showed
mostly under-expression of these genes with respect to
untreated one and such under-expression was consistent
and significant in RAN + lime administered mice. How-
ever, the expression of all these genes in BMC did not
change in any significant manner except over-expression
of Mad2 and Bub1 was noted in the BMC of mouse col-
lected after 260 days of administeration.Analysis of over-expression of genes through
immunoblotting
Levels of p53, p65, Bax and Securin in BMC from mice
after administeration of RAN extract with or without
lime for 60, 90 and 180 days, and those esophagus and
stomach after 180 days of feeding were examined by im-
munoblotting. Levels of these proteins were also tested
from the cells collected tissue-wise from the untreated
mice. Results indicate that the expression of p53, p65,
Bax and Securin are elevated significantly in all the
tissues in RAN administered mice. Such enhancement
was significantly higher in RAN + lime than in only
RAN administered mice (Figure 5).
Flow cytometric studies on cell cycle and detection of
apoptotic cells by dual staining and immunoblotting
Flow cytometric analysis of DNA content in bone mar-
row, esophagus and stomach cells of mouse collected
after 260 days of RAN + lime administration (Figure 6A),
showed that there was an increase in G1 phase cells
both in bone marrow and esophagus with respect to
Table 1 Chromosome analysis of mouse bone marrow cells after exposure to RAN extract with or without lime
Treatment pattern Treatment days Total spread scored Chromosome no. Aneuploidy Premature sister
37 38 39 40 41 42 >60 % (Mean) Chromatid separation %
Untreated 0 110 110 0 0
104 104 0 0
RAN 120 105 1 1 103 1.9 17.5
120 2 1 2 115 4.1 18.7
105 1 2 102 2.8 (2.9) 18.3 (18.2)
RAN + lime 100 2 2 1 95 5.0 31.7
105 2 2 3 98 6.6 28.6
110 3 2 1 103 1 6.4 (6.0) 28.3 (29.5)
p = 0.015a
RAN 180 101 1 2 1 97 3.9 18.0
124 2 2 1 119 4.0 17.7
114 3 2 1 108 5.3 (4.4) 19.4 (18.4)
RAN + lime 112 3 3 3 103 8.0 32.6
105 2 2 1 98 1 1 6.6 34.9
110 4 2 101 2 1 8.2 (7.6) 35.6 (34.4)
p = 0.002a
RAN + lime 220 232 6 9 12 194 7 2 2 16.4 8.2
(with advanced tumor) 256 234 5 4 7 208 5 2 3 11.1 (13.8) 7.1 (7.6)
a statistically significant in paired t-test; two-tailed p value was shown.
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of cells in sub-G1 phase was increased, which could be
attributed due to apoptotic cell death. To confirm this,
dual staining with annexinV and PI was performed. Data
in Figure 5B indicate increased positive staining with
Annexin-V in quadrant 2 and 3 in stomach cells but not
in esophageal cells of RAN + lime administered mice.
Interestingly, flow cytometric analysis of tumor cells col-
lected from the mice which developed tumor in stomach
after 220 and 256 days of continuous administeration of
RAN and lime, revealed significant reduction in G1 cells
with a concomitant rise in the sub-G1 cells (Figure 6A).
Dual staining indicates that sub-G1 cells are mostly
necrotic dead cells (quadrant 4) (Figure 6B). Significantly
higher level of p53 and Bax proteins were observed in
tumor than normal stomach cells (Figure 6C). However,
PARP was found to be absent in both the tumor cells of
the stomach although PARP and its 29 kD cleaved product
were present in normal stomach samples (Figure 6C).
Discussion
The present study was undertaken to see if ad libitum
administeration of RAN extract with or without lime in
drinking water can induce esophagus or stomach cancer
in mouse and if it does, what initial processes are in-
volved. In this study, the mice were given the whole
RAN-extract with and without lime in order to mimic
the human consumption style of RAN. Moreover, thedose was also increased periodically as it happens to
human. Our results showed that both RAN with and
without lime induce stomach cancer, although, it is
noted that presence of lime with RAN promoted higher
cell transformation and thereby developed stomach
cancer earlier than RAN alone. It appears that the
cancer was induced in stomach because of the greater
exposure its lining had to RAN while the esophagus
lining was exposed only briefly during drinking the RAN
mixed water.
It has been demonstrated earlier that an alkaline pH is
ideal for generating ROS by autoxidation of areca-nut
polyphenols [6,7]. It was also shown that the catechin
fraction of areca-nut extract actively generates ROS at
alkaline pH which induces DNA damage in vitro [21,22].
Therefore, the yield of ROS in presence of lime could be
a contributing factor for the induction of higher cell
damages which promoted higher cell transformation in
the present case.
The gradual and significant increase in the frequency
of precocious anaphase in the BMC of the mouse
administered with RAN is interesting. The degree of in-
crease of precocious anaphase was more in the mouse
administered with RAN + lime. Such premature sister
chromatids separation has been observed in yeast Mad2
mutants and Drosophila Bub1 mutants [23,24]. It was
demonstrated that partial loss of Mad2 in Hct 116 cells
and in murine primary embryonic fibroblasts showed
Mad 2
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Figure 4 Upper panel- Expression of mitotic checkpoint genes in mouse bone marrow (BM), esophagus and stomach cells after
exposure with RAN extract with or without lime for 120, 180 and 260 days. Lower panel- Quantitative densitometric analysis of the
expression profile of mitotic checkpoint genes mRNA level in esophagus and stomach cells after 260 days of exposure was shown. The values are
the mean ± SEM of three independent experiments. The values are normalized to respective GAPDH values. * p < 0.05; ** p < 0.01;
*** p < 0.001. Significantly different compared with negative/positive control (as determined by paired t-test).
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presence of spindle inhibitors and an elevated rate of
chromosome mis-segregation events in the absence of
these agents [18]. Interestingly, in the present study, such
precocious anaphases were observed during early days of
exposure which might subsequently lead to production of
abnormal cells. Indeed, we observed aneuploid cells in
BMC of mouse given RAN with and without lime, initially
at low frequency and that was increased gradually irre-
spective of the development of stomach cancer.
It is likely that the observed precocious anaphase cells
lead to chromosome missegregation and subsequent
aneuploidy after exposure of 120 days onwards. Such
abnormal cells either die apoptotically / necrotically or
could be trapped by the cell cycle checkpoints which
usually depends on p53 [25]. In fact, the present flow
cytometric analysis of bone marrow and esophageal cells
of mouse collected after 260 days of RAN + lime expos-
ure showed that the cell cycle progression is arrested at
G1 phase with upregulated expression of p53 protein.
However, these cells do not show any apoptosis as
revealed from the present flow cytometry studies. In
contrast, G1 arrest was not observed in stomach cells,
rather sub-G1 phase cells were more frequent whichcould be a mixture of apoptotic as well as necrotic dead
cells. To obtain additional evidence for apoptosis, we
tested whether the dying cells exhibited other characteris-
tics of programmed cell death. Immunoblotting demon-
strated that RAN with or without lime caused p53
accumulation and activation of downstream proapoptotic
gene like Bax which culminated in apoptotic cell death in
non-cancerous stomach cells. On the other hand,
cytograms of Annexin V versus PI fluorescence intensities
for stomach cancer tissue revealed absence of apoptotic
cells in spite of a significant rise in the percentage of sub-
G1 cells. This suggests, that in cancer tissue of stomach,
cells were dying because of necrosis rather than apoptosis.
It is surprising that there was a higher expression of
Bax while PARP was absent in the stomach tumor cells.
Apoptotic pathways are considered to be autonomous
tumour surveillance mechanisms in a cell whereas eva-
ding apoptosis is considered one of the hallmarks of
cancer [26]. Bax is a pro-apoptotic member of the Bcl-2
family and is expected to act as tumor suppressor.
Therefore, higher expression of Bax noted in the present
study is unusual. However, there are some earlier reports
in which a higher expression of Bax in oral squamous
cell carcinoma has been noted [27,28]. The absence of
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Figure 5 Upper panel- Representative western blotting detection of p65, p53, securin, bax and β-actin in mouse bone marrow (BM),
esophagus and stomach cells after exposure with RAN extract with or without lime. For BM, cells were collected after 60, 120 and
180 days, whereas for esophagus and stomach, cells were collected only after 180 days of exposure. β-actin was used as loading control. Lower
panel- Quantitative densitometric analysis of the level of proteins of the above mentioned genes in bone marrow, esophagus and stomach cells
after 180 days of exposure was shown. The values are the mean ± SD of three independent experiments. The values are normalized to respective
β-actin values. * p < 0.05; ** p < 0.01 Significantly different compared with negative/positive control (as determined by paired t-test).
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aneuploidy in the cancer cells, so that the chromosome
on which PARP gene resides was lost. Additionally, in-
hibition or absence of PARP has also been noted in several
disease models, such as stroke, myocardial infarction, and
ischemia [29] in which cells are dying predominantly by
programmed necrotic cell death. Further studies are nee-
ded to better understand the reasons for absence of PARP
in the RAN+ lime induced stomach cancer cells.
In view of the reports that defective mitotic checkpoint
cause chromosomal instability and aneuploidy [23,24], we
examined expression of Aurora kinases (Aurora-A and
Aurora-B), Mad2 and Bub1 in bone marrow, esophagus
and stomach cells of the mouse administered with RBN
with or without lime for 260 days. Expression of all these
genes was found to be significantly downregulated in
stomach and esophageal cells of treated mouse. However,
the degree of downregulation was more in RAN+ lime
treated mice. Over-expression of Mad2 and Bub1 was
noted in BMC of the treated mice. It has been reported
that arecoline, a component of areca-nut, upregulated the
spindle assembly checkpoint genes like Aurora A, BubR1
and Mps1 which led to distorted organization of mitoticspindles and misalignment of chromosomes [30]. The
silencing of Aurora B by RNA-mediated interference leads
to abnormal chromosome segregation and multinucleated
cells as a consequence of cytokinesis failure [31]. Reduced
Bub1 expression has been detected in a subset of lung,
colon and pancreatic cancers [32,33]. Insufficiency of
Bub1 increased cancer risk in mouse which showed higher
frequency of aneuploid cells [34]. The alterations in the
expression of these mitotic check-point genes observed in
the present study also thus appears to play a significant
role in premature sister-chromatid separation followed by
chromosome mis-segregation.
Securin, also known as pituitary tumor transforming
gene, is a key mitotic check-point protein involved at
the metaphase-anaphase interface. Securin, which is
involved in chromatid separation, has transforming
activity in vitro and is over expressed in many tumors
[35,36]. Over-expression of Securin gene in bone
marrow, esophagus and stomach cells was noted even
during early days of RAN exposure. Over-expression of
Securin has been shown to induce aneuploidy, arising
from chromatid missegeration in human cell [37]. It has
been shown that over-expression of Securin inhibited
Bone 
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Figure 6 Analysis of cell cycle and apoptosis in mice treated with RAN with lime (A) Analysis of cell cycle after 260 days of exposure
with RAN extract with lime in bone marrow, esophagus and stomach cells of mouse and also from stomach tumor cells.
(B) Representative cytograms of Annexin V versus PI fluorescence intensities as determined by flow cytometric analysis in mouse esophagus and
stomach cells after 260 days of exposure with RAN with lime and from stomach tumor cells. Within a cytogram, quadrant 1 and 2 represent early
and late apoptotic cells, respectively; quadrant 3, viable cells; quadrant 4, dead cells. (C) Western blotting for apoptotic markers in normal
(untreated) and tumor stomach cells. β-actin was used as loading control.
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activity by repressing Ku heterodimer function [38].
Therefore, Securin over-expression may reflect a greater
DNA damage, particularly in stomach which was max-
imally exposed to RAN extract and lime.
Besides Securin, we also observed increased expression
of p53 and p65 (relA) in all the tissues of mice that were
exposed to RAN-extract with or without lime. It has
been demonstrated that genotoxic stress elicits a series
of posttranslational modifications on p53, which con-
tribute to its stabilization, nuclear accumulation and bio-
chemical activation [14]. Mutation in p53 gene is known
to be associated with a variety of human and experimen-
tal animal cancers. The accumulation of p53 protein or
its stabilization in all the RAN treated (with or without
lime) cells is an important indicator of the presence of
mutant p53 protein as proposed earlier [39]. The p65,
which is one of the constituent subunit of hetero- or
homo-dimers of Nuclear factor–kappa B (NF-kB), acts
as a regulator of expression of multiple genes that con-
trol cell proliferation and cell survival [40]. Activation ofNF-κB is frequently seen in tumors and plays a pivotal
role in linking inflammation to tumor development and
progression [41,42].
Research over the years has generated sufficient evi-
dence to implicate areca-nut, as a carcinogen in humans
[43,44]. In addition to oral, significant increase in the
incidence of cancers of the esophagus, liver, stomach,
pancreas, larynx and lung were seen among areca-
nut-chewers [45]. Present study shows that RAN can
induce stomach cancer and the development of such
cancer will be accelerated if lime combines with RAN.
Present study provides some insights into the paths that
result in aneuploidy and consequently to cancer follow-
ing RAN treatment. It seems that CIN is a quantitative
trait influenced by many genes. Here we show that
Securin over-expression even at earlier days can elevate
CIN and subsequently under-expression of other mitotic
check-point genes and over-expression of p65 and many
other relevant genes may be a likely cause of its onco-
genicity. Present study also highlights the importance
of cytogenetic marker like- premature sister-chromatid
Kurkalang et al. BMC Cancer 2013, 13:315 Page 11 of 12
http://www.biomedcentral.com/1471-2407/13/315separation, as a screening for identification of mitotic
check point defects and can be used in heavy-chewers
samples.
Conclusions
Present study suggested (a) RAN induces stomach
cancer, however, presence of lime promoted higher cell
transformation and thereby developed cancer earlier,
(b) perturbations in components of the chromosome
segregation machinery could be involved in the initial
process of carcinogenicity and (c) the importance of pre-
cocious anaphase as a screening marker for identifica-
tion of mitotic check point defects during early days.
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